Scarica l'app Stockscreener
27.18
5.10%
1.32
Precedente Chiudi:
$25.86
Aprire:
$25.9766
Volume 24 ore:
8,230
Relative Volume:
1.10
Capitalizzazione di mercato:
$107.04M
Reddito:
$17,000
Utile/perdita netta:
$-23.87M
Rapporto P/E:
-8.7115
EPS:
-3.12
Flusso di cassa netto:
$-22.03M
1 W Prestazione:
+0.67%
1M Prestazione:
+9.07%
6M Prestazione:
+69.88%
1 anno Prestazione:
+64.33%
Intervallo 1D:
$25.98
$27.68
Intervallo di 1 settimana:
$22.91
$27.68
Portata 52W:
$13.15
$33.16
Vtv Therapeutics Inc Stock (VTVT) Company Profile
Nome
Vtv Therapeutics Inc
Settore
Industria
Telefono
336-841-0300
Indirizzo
3980 PREMIER DR, HIGH POINT, NC
Confronta VTVT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VTVT
Vtv Therapeutics Inc
|
27.18 | 101.84M | 17,000 | -23.87M | -22.03M | -3.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Vtv Therapeutics Inc Stock (VTVT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-19 | Iniziato | BTIG Research | Buy |
| 2019-05-30 | Iniziato | H.C. Wainwright | Buy |
| 2018-04-10 | Downgrade | Stifel | Buy → Hold |
| 2018-03-08 | Iniziato | ROTH Capital | Buy |
| 2018-02-08 | Iniziato | Northland Capital | Outperform |
| 2016-09-26 | Iniziato | H.C. Wainwright | Buy |
| 2015-09-04 | Iniziato | Canaccord Genuity | Buy |
| 2015-08-24 | Iniziato | Piper Jaffray | Overweight |
| 2015-08-24 | Iniziato | Stifel | Buy |
Mostra tutto
Vtv Therapeutics Inc Borsa (VTVT) Ultime notizie
How vTv Therapeutics Inc. (5VT0) stock moves in volatile trading sessionsJuly 2025 PostEarnings & Free Real-Time Volume Trigger Notifications - Newser
Can vTv Therapeutics Inc. (5VT0) stock hit consensus price targetsMarket Risk Analysis & Long-Term Safe Investment Ideas - Newser
Why vTv Therapeutics Inc. stock is a must watch in 20252025 Key Highlights & High Accuracy Buy Signal Tips - Newser
Is vTv Therapeutics Inc. stock resilient to inflationSell Signal & Stock Market Timing Techniques - Newser
How dovish Fed policy supports vTv Therapeutics Inc. (5VT0) stockTrade Ideas & Free Verified High Yield Trade Plans - Newser
What makes vTv Therapeutics Inc. (5VT0) stock appealing to growth investorsTrade Risk Assessment & Daily Technical Forecast Reports - Newser
Published on: 2025-12-03 00:26:57 - Newser
Liquidity Mapping Around (VTVT) Price Events - news.stocktradersdaily.com
Why vTv Therapeutics Inc. stock remains a top recommendationJuly 2025 Catalysts & Weekly High Momentum Picks - Newser
What technical patterns form on vTv Therapeutics Inc. (5VT0) stock chartsQuarterly Risk Review & Safe Capital Growth Stock Tips - Newser
Here's Why We're Not Too Worried About vTv Therapeutics' (NASDAQ:VTVT) Cash Burn Situation - Sahm
Will vTv Therapeutics Inc. (5VT0) stock attract long term capital inflowsJuly 2025 Outlook & High Accuracy Trade Alerts - Newser
Why analysts remain bullish on vTv Therapeutics Inc. stock2025 Top Gainers & AI Enhanced Trading Alerts - Newser
Is vTv Therapeutics Inc a good long term investmentEarnings Call Summaries & Fast Growing Trading Ideas - earlytimes.in
What drives vTv Therapeutics Inc stock priceTake Profit Strategies & Exceptional Growth Portfolio - earlytimes.in
vTv Therapeutics (NASDAQ:VTVT) Shares Pass Above 50-Day Moving AverageHere's Why - MarketBeat
[EFFECT] vTv Therapeutics Inc. SEC Filing - Stock Titan
Does vTv Therapeutics (VTVT) Have the Potential to Rally 25.17% as Wall Street Analysts Expect? - sharewise.com
Why (VTVT) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
vTv Therapeutics (NASDAQ:VTVT) Raised to Strong-Buy at BTIG Research - MarketBeat
vTv Therapeutics (NASDAQ:VTVT) Upgraded at BTIG Research - Defense World
BTIG Research Initiates Coverage on vTv Therapeutics (NASDAQ:VTVT) - MarketBeat
Is vTv Therapeutics Inc. (5VT0) stock included in top ETFs2025 Historical Comparison & Entry Point Strategy Guides - newser.com
Why retail investors favor vTv Therapeutics Inc. stock2025 Price Action Summary & Weekly Consistent Profit Watchlists - newser.com
Will vTv Therapeutics Inc. (5VT0) stock beat international competitionBond Market & Long-Term Safe Investment Plans - newser.com
What makes vTv Therapeutics Inc. stock attractive to growth fundsPortfolio Value Report & Low Risk High Win Rate Stock Picks - newser.com
Can vTv Therapeutics Inc. stock sustain market leadershipJuly 2025 Spike Watch & Low Risk High Win Rate Stock Picks - newser.com
How vTv Therapeutics Inc. (5VT0) stock benefits from digital adoptionShort Setup & Weekly Chart Analysis and Guides - newser.com
Will vTv Therapeutics Inc. (5VT0) stock justify high valuationJuly 2025 Gainers & Safe Capital Growth Stock Tips - newser.com
Has vTv Therapeutics Inc. found a price floorWatch List & Free Expert Verified Stock Movement Alerts - newser.com
BTIG Maintains VTv Therapeutics(VTVT.US) With Buy Rating, Maintains Target Price $40 - 富途牛牛
BTIG Initiates Coverage of vTv Therapeutics (VTVT) with Buy Recommendation - Nasdaq
Will vTv Therapeutics Inc. stock deliver consistent dividends2025 Support & Resistance & Daily Oversold Bounce Ideas - newser.com
Can vTv Therapeutics Inc. (5VT0) stock attract ESG investmentsQuarterly Earnings Report & Weekly Consistent Profit Watchlists - newser.com
BTIG Initiates Coverage on vTv Therapeutics (VTVT) with a "Buy" Rating | VTVT Stock News - GuruFocus
Is vTv Therapeutics Inc. (5VT0) stock supported by strong fundamentalsQuarterly Trade Review & Weekly Market Pulse Updates - newser.com
Why vTv Therapeutics Inc. stock is recommended by analystsAnalyst Downgrade & Verified Momentum Stock Ideas - newser.com
Vtv Therapeutics Inc Azioni (VTVT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.10%
1.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):